Peter Radovich - Net Worth and Insider Trading
Peter Radovich Net Worth
The estimated net worth of Peter Radovich is at least $4 Million dollars as of 2026-09-13. Peter Radovich is the PRESIDENT AND COO of Mirum Pharmaceuticals Inc and owns about 40,272 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $4 Million. Peter Radovich is also the See Remarks of Global Blood Therapeutics Inc and owns about 6,817 shares of Global Blood Therapeutics Inc (GBT) stock worth over $466,896. Details can be seen in Peter Radovich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Radovich has not made any transactions after 2026-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Radovich
Peter Radovich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Radovich owns 3 companies in total, including Mirum Pharmaceuticals Inc (MIRM) , Global Blood Therapeutics Inc (GBT) , and Rain Oncology Inc (RAIN) .
Click here to see the complete history of Peter Radovich’s form 4 insider trades.
Insider Ownership Summary of Peter Radovich
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2026-03-16 | Chief Operating Officer |
| GBT | Global Blood Therapeutics Inc | 2018-02-01 | See Remarks |
| RAIN | Rain Oncology Inc | 2021-04-22 | director |
Peter Radovich Latest Holdings Summary
Peter Radovich currently owns a total of 2 stocks. Among these stocks, Peter Radovich owns 40,272 shares of Mirum Pharmaceuticals Inc (MIRM) as of March 16, 2026, with a value of $4 Million and a weighting of 89.44%. Peter Radovich also owns 6,817 shares of Global Blood Therapeutics Inc (GBT) as of February 1, 2018, with a value of $466,896 and a weighting of 10.56%.
Latest Holdings of Peter Radovich
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2026-03-16 | 40,272 | 98.22 | 3,955,516 |
| GBT | Global Blood Therapeutics Inc | 2018-02-01 | 6,817 | 68.49 | 466,896 |
Holding Weightings of Peter Radovich
Peter Radovich Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Radovich has made a total of 15 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 16,515 shares on March 16, 2026, which brought Peter Radovich around $2 Million.
According to the SEC Form 4 filings, Peter Radovich has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 812 shares on February 1, 2018, which brought Peter Radovich around $46,528.
Insider Trading History of Peter Radovich
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Peter Radovich Trading Performance
GuruFocus tracks the stock performance after each of Peter Radovich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Radovich is -12.39%. GuruFocus also compares Peter Radovich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Radovich within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Radovich's insider trading performs compared to the benchmark.
Performance of Peter Radovich
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.47 | | | | | |
| Relative Return to S&P 500(%) | 2.87 | | | | | |
Peter Radovich Ownership Network
Ownership Network List of Peter Radovich
Ownership Network Relation of Peter Radovich
Peter Radovich Owned Company Details
What does Mirum Pharmaceuticals Inc do?
Who are the key executives at Mirum Pharmaceuticals Inc?
Peter Radovich is the Chief Operating Officer of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , director & President and CEO Christopher Peetz , and CHIEF FINANCIAL OFFICER Eric Bjerkholt .
Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary
Over the past 18 months, Peter Radovich made 5 insider transaction in Mirum Pharmaceuticals Inc (MIRM) with a net sale of 32,550. Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 126,343 shares made by Jolanda Howe , a net sale of 271,301 shares made by Christopher Peetz , and a net sale of 29,180 shares made by Saira Ramasastry .
In summary, during the past 3 months, insiders sold 128,814 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 128,814 shares. During the past 18 months, 680,937 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 131,974 shares were bought by its insiders, resulting in a net sale of 548,963 shares.
Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirum Pharmaceuticals Inc Insider Transactions
Peter Radovich Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Radovich. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Peter Radovich's mailing address is: Foster City Ca 94404.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
